Resources Contact Us Home
Assay for methylation in the GST-Pi gene

Image Number 15 for United States Patent #8088577.

A diagnostic or prognostic assay is disclosed for a disease of condition characterized by abnormal methylation of cytosine at side or sites within the glutathione-S-transferase (GST) Pi gene and/or its regulatory flanking sequences (e.g., prostate cancer and liver cancer). The assay comprises: (i) isolating DNA from said subject, and (ii) determining (e.g., by selective PCR amplification) the presence of abnormal methylation of cytosine at a site or sites within the GST-Pi gene and/or its regulatory flanking sequences.

  Recently Added Patents
Table base
Keypad assembly for electronic devices
Register files for a digital signal processor operating in an interleaved multi-threaded environment
Semiconductor device and manufacturing method thereof
System and method for hybrid risk modeling of turbomachinery
Rim for a TV receiver
Systems and methods for building axes, co-axes and paleo-geographic coordinates related to a stratified geological volume
  Randomly Featured Patents
Projector with adjustably positioned image plate
Method of automatically framing a reversal film provided with edge notches
Manufacturing integrated circuit cards
Multiple stage device and method for manufacturing a woven fabric
Multi-Resonance converter
Mixed turf and method for its production
Integrated investment management system with network datafeed and incremental database refresh
Grounded isolation system
Fastening arrangement for a vehicle wheel consisting of an interior wheel shell and of an exterior wheel shell
Transfer of mobile subscriber context in cellular networks using extended routing protocol